文献速递肾移植

已故供者尿MCP-1与肾移植结局的关联研究

Associations between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes.
PubMed 文献 · Kidney Int Rep · 2017-03-31

结果显示供者尿MCP-1与无DGF受者的6个月eGFR呈弱独立正相关,但与DGF及移植物失败无独立关联。

要点

  • 供者尿MCP-1在发生AKI的供者中显著升高。
  • 供者尿MCP-1与受者DGF及移植物失败无独立关联。
  • 无DGF受者中,供者尿MCP-1较高与6个月eGFR较高独立相关。

核心结论

  • 供者尿MCP-1仅与无DGF受者的6个月eGFR呈弱独立正相关,与移植物失败无关联,临床价值有限。

主要发现

  • 111例(9%)供者发生AKI,其尿MCP-1中位数(IQR)为1.35(0.41-3.93)ng/ml,高于无AKI供者的0.32(0.11-0.80)ng/ml,p<0.001。
  • 756例(31%)受者发生DGF,但尿MCP-1与DGF无独立关联。
  • 无DGF受者中,供者尿MCP-1每倍增对应6个月eGFR高0.77(0.10,1.45)ml/min/1.73m2,为独立关联。
  • 中位随访约2年,尿MCP-1与移植物失败无独立关联。
  • 泵灌注液中MCP-1浓度在灌注过程中显著升高,但与DGF或6个月eGFR无关联。

临床怎么用

  • 供者尿MCP-1不宜作为预测DGF或移植物失败的生物标志物。
  • 供者尿MCP-1可能有助于识别无DGF受者中6个月eGFR较高的情形,但证据有限。

局限性

  • 本研究为观察性队列子研究,结果需进一步验证。
  • 供者尿MCP-1与移植物失败无关联,限制了其临床实用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Existing methods to predict recipient allograft function during deceased-donor kidney procurement are imprecise. Understanding the potential renal reparative role for monocyte chemoattractant protein-1 (MCP-1), a cytokine involved in macrophage recruitment after injury, might help predict allograft outcomes. METHODS: We conducted a sub-study of the multicenter prospective Deceased Donor Study cohort, which evaluated deceased kidney donors from five organ procurement organizations from May 2010 to December 2013. We measured urine MCP-1 (uMCP-1) concentrations from donor samples collected at nephrectomy to determine associations with donor acute kidney injury (AKI), recipient delayed graft function (DGF), 6-month estimated GFR (eGFR), and graft failure. We also assessed perfusate MCP-1 concentrations from pumped kidneys for associations with DGF and 6-month eGFR. RESULTS: AKI occurred in 111 (9%) donors. Median (interquartile range) uMCP-1 concentration was higher in donors with AKI compared to donors without AKI (1.35 [0.41-3.93] ng/ml vs. 0.32 [0.11-0.80] ng/ml, p<0.001). DGF occurred in 756 (31%) recipients, but uMCP-1 was not independently associated with DGF. Higher donor uMCP-1 concentrations were independently associated with higher 6-month eGFR in those without DGF [0.77 (0.10, 1.45) ml/min/1.73m2 per doubling of uMCP1]. However, there were no independent associations between uMCP-1 and graft failure over a median follow-up of about 2 years. Lastly, perfusate MCP-1 concentrations significantly increased during pump perfusion but were not associated with DGF or 6-month eGFR. CONCLUSION: Donor uMCP-1 concentrations were modestly associated with higher recipient 6-month eGFR in those without DGF. However, the results suggest that donor uMCP-1 has minimal clinical utility given no associations with graft failure.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Mansour SG, Puthumana J, Reese PP, et al. Associations between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes. Kidney Int Rep. 2017. PMID: 28730184. doi:10.1016/j.ekir.2017.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。